Melanoma movement

Although the disease represents less than 5% of all skin cancer, it causes more than 80% of skin cancer deaths

The list of treatment options for melanoma in Australia is growing almost as quickly as the rate of diagnosis.

man getting chemotherapy

In April 2015, pembrolizumab (Keytruda), a new treatment for melanoma, received considerable media attention after its approval by the TGA coincided with the presentation of promising results at the annual scientific meeting of the American Association for Cancer Research.

The list of treatment options available for patients with metastatic melanoma has grown dramatically in recent years, albeit from a low base.